🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the Pharmacokinetics of MNTX in healthy control su...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-03
Trial ID
NCT01367509
Treatments Being Tested
The primary purpose of the protocol is to evaluate the safety, efficacy, an...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00529087
Treatments Being Tested
This is a double-blind, randomized, study at a single clinical site investi...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2002-10
Trial ID
NCT01367561
Treatments Being Tested
This study will employ a single-center, randomized, double-blind parallel-g...
Status
Completed
Location
Progenics Pharmaceuticals
Start Date
2004-11
Trial ID
NCT01363323
Treatments Being Tested
This is an open-label, multicenter extension of study 3200K1-4000-WW that w...
Status
Completed
Location
Salix Investigational Site
Start Date
2008-07
Trial ID
NCT00672139
Treatments Being Tested
It is hypothesized that using methylnaltrexone in addition to pain killer n...
Status
Withdrawn
Location
Hahnemann University Hospital
Start Date
2010-10
Trial ID
NCT01360372
Treatments Being Tested
This double-blind, randomized, two-cohort, placebo-controlled, parallel gro...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2006-10
Trial ID
NCT01366365
Treatments Being Tested
This study evaluates the safety of multiple doses of IV MNTX in normal heal...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2002-04
Trial ID
NCT01367587
Treatments Being Tested
This is an open-label, radiotracer study, to be conducted in healthy, norma...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2005-06
Trial ID
NCT01367483
Treatments Being Tested
Ticagrelor is associated with more prompt and potent antiplatelet effects c...
Status
Completed
Location
University of Florida
Start Date
2015-08
Trial ID
NCT02403830
Treatments Being Tested